Cancer Management and Research (Feb 2021)

Dissection of Level III Axillary Lymph Nodes in Breast Cancer

  • Hu J,
  • Xia X,
  • Yang H,
  • Yu Y

Journal volume & issue
Vol. Volume 13
pp. 2041 – 2046

Abstract

Read online

Jiejie Hu, Xianghou Xia, Hongjian Yang, Yang Yu Breast Surgery Department, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Cancer and Basic Medicine (IBMC), Chinese Academy of Sciences, Hangzhou City, Zhejiang Province, People’s Republic of ChinaCorrespondence: Yang YuBreast Surgery Department, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Cancer and Basic Medicine (IBMC), Chinese Academy of Sciences, No. 1, Banshan East Road, Gongshu District, Hangzhou City, Zhejiang Province, 310022, People’s Republic of ChinaTel +8613758252681Email [email protected]: Axillary lymph node dissection is an indispensable step in modified radical mastectomy for breast cancer. It is the most reliable method and the golden standard to determine the status of axillary lymph nodes. It is also of great importance to evaluate the prognosis and develop treatment plans for breast cancer patients. Axillary lymph node dissection can be anatomically divided into levels I, II, and III. Level I and Level II axillary lymph dissection is the standard clinical treatment of axillary lymph nodes positive breast cancer, whereas level III axillary lymph node dissection has been controversial. Level III axillary lymph node metastasis is one of the important factors that can easily cause distant metastasis and recurrence. It is also an important index to estimate the prognosis of breast cancer patients. To facilitate the decision of whether or not to perform level III lymph node dissection, we reviewed the indications, complications, and surgical procedures of level III lymph node dissection.Keywords: breast cancer, axillary lymph node dissection, level III

Keywords